These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8411102)

  • 41. Simian immunodeficiency virus DNA vaccine trial in macaques.
    Robinson HL; Lu S; Mustafa F; Johnson E; Santoro JC; Arthos J; Winsink J; Mullins JI; Montefiori D; Yasutomi Y
    Ann N Y Acad Sci; 1995 Nov; 772():209-11. PubMed ID: 8546394
    [No Abstract]   [Full Text] [Related]  

  • 42. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.
    Burns DP; Desrosiers RC
    J Virol; 1991 Apr; 65(4):1843-54. PubMed ID: 2002545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys.
    von Gegerfelt A; Nilsson C; Putkonen P; Broliden K
    Vaccine; 1994 Oct; 12(13):1203-8. PubMed ID: 7839725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional and immunological characterization of SIV envelope glycoprotein produced in genetically engineered mammalian cells.
    Planelles V; Haigwood NL; Marthas ML; Mann KA; Scandella C; Lidster WD; Shuster JR; Van Kuyk R; Marx PA; Gardner MB
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):889-98. PubMed ID: 1760229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The SIVmac specific cytotoxic T lymphocyte response in the acutely infected rhesus monkey.
    Letvin NL; Reimann KA; Yasutomi Y; Ringler DJ; Yamamoto H
    Curr Top Microbiol Immunol; 1994; 188():175-84. PubMed ID: 7924426
    [No Abstract]   [Full Text] [Related]  

  • 46. Simian immunodeficiency virus (mac 251-32H) transmembrane protein sequence remains conserved throughout the course of infection in macaques.
    Slade A; Jones S; Almond N; Kitchin P
    AIDS Res Hum Retroviruses; 1993 Feb; 9(2):133-9. PubMed ID: 8457380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus.
    Kodama T; Burns DP; Silva DP; Veronese FD; Desrosiers RC
    J Virol; 1991 Apr; 65(4):2010-8. PubMed ID: 1705994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeys.
    Negri DR; Baroncelli S; Michelini Z; Macchia I; Belli R; Catone S; Incitti F; ten Haaft P; Corrias F; Cranage MP; Polyanskaya N; Norley S; Heeney J; Verani P; Titti F
    J Med Primatol; 2001 Aug; 30(4):197-206. PubMed ID: 11555138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD4+ T cell responses to simian immunodeficiency virus.
    Mills KH; Jones WC
    Curr Top Microbiol Immunol; 1994; 188():161-73. PubMed ID: 7924425
    [No Abstract]   [Full Text] [Related]  

  • 50. Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene.
    Ibuki K; Ido E; Funahashi S; Miura T; Hayami M; Shida H
    Vaccine; 1999 Oct; 18(5-6):511-6. PubMed ID: 10519941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants.
    Gonzalo RM; Rodríguez D; García-Sastre A; Rodríguez JR; Palese P; Esteban M
    Vaccine; 1999 Feb; 17(7-8):887-92. PubMed ID: 10067695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization of macaque monkeys with low- and high-dose regimens of SIVmac results in different immune responses.
    Dittmer U; Bodemer W; Hunsmann G; Voss G
    Immunol Today; 1994 Feb; 15(2):90-1. PubMed ID: 8155269
    [No Abstract]   [Full Text] [Related]  

  • 53. Heterologous HIV-2 challenge of rhesus monkeys immunized with recombinant vaccinia viruses and purified recombinant HIV-2 proteins.
    Vogt G; le Grand R; Vaslin B; Boussin F; Auboyer MH; Rivière Y; Putkonen P; Sonigo P; Kieny MP; Girard M
    Vaccine; 1995 Feb; 13(2):202-8. PubMed ID: 7625117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced T- and B-cell responses to simian immunodeficiency virus (SIV)agm, SIVmac and human immunodeficiency virus type 1 Gag DNA immunization and identification of novel T-cell epitopes in mice via codon optimization.
    Siegismund CS; Hohn O; Kurth R; Norley S
    J Gen Virol; 2009 Oct; 90(Pt 10):2513-2518. PubMed ID: 19587137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological responses and viral modulatory effects of vaccination with recombinant modified vaccinia virus Ankara (rMVA) expressing structural and regulatory transgenes of simian immunodeficiency virus (SIVmac32H/J5M).
    Berry N; Stebbings R; Brown S; Christian P; Thorstensson R; Ahmed RK; Davis L; Ferguson D; D'Arcy N; Elsley W; Hull R; Lines J; Wade-Evans A; Stott J; Almond N
    J Med Primatol; 2007 Apr; 36(2):80-94. PubMed ID: 17493138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of biologically active envelope glycoprotein from the acutely pathogenic simian immunodeficiency virus SIVsmmPBj.
    González SA; Affranchino JL; Burny A
    Virus Genes; 1994 Jan; 8(1):75-8. PubMed ID: 7911608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of persistent infections with vaccinia virus recombinants to introduce alterations in foreign proteins: an application to HIV-1 env protein.
    Esteban M; Ramón Rodríguez J; Jimenez V; Rodríguez D
    Virus Res; 1996 Dec; 46(1-2):45-56. PubMed ID: 9029776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission.
    Shafferman A; Lewis MG; McCutchan FE; Benveniste RE; Jahrling PB; Hickman RL; Lai CY; Burke DS; Eddy GA
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1483-7. PubMed ID: 1281660
    [No Abstract]   [Full Text] [Related]  

  • 59. Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network.
    Gorse GJ; Belshe RB; Newman FK; Frey SE
    Vaccine; 1992; 10(6):383-8. PubMed ID: 1534641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humoral and cytotoxic T cell immune responses to internal and external structural proteins of simian virus 5 induced by immunization with solid matrix-antibody-antigen complexes.
    Randall RE; Young DF
    J Gen Virol; 1988 Oct; 69 ( Pt 10)():2505-16. PubMed ID: 3262715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.